I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 24% ± 3% | |
| dendritic cell | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 24% ± 3% | |
| dendritic cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of ABCF3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 10449.96 | 258 / 258 | 100% | 91.54 | 230 / 230 |
| esophagus | 100% | 2651.74 | 1445 / 1445 | 100% | 34.99 | 183 / 183 |
| liver | 100% | 2738.04 | 226 / 226 | 100% | 30.21 | 406 / 406 |
| lung | 100% | 2866.95 | 578 / 578 | 100% | 53.19 | 1155 / 1155 |
| ovary | 100% | 3695.89 | 180 / 180 | 100% | 41.34 | 430 / 430 |
| pancreas | 100% | 2386.55 | 328 / 328 | 100% | 37.07 | 178 / 178 |
| prostate | 100% | 3537.71 | 245 / 245 | 100% | 47.60 | 502 / 502 |
| skin | 100% | 3170.69 | 1809 / 1809 | 100% | 47.34 | 472 / 472 |
| stomach | 100% | 2621.75 | 359 / 359 | 100% | 31.09 | 286 / 286 |
| uterus | 100% | 3159.42 | 170 / 170 | 100% | 55.54 | 459 / 459 |
| thymus | 100% | 3736.26 | 653 / 653 | 100% | 38.76 | 604 / 605 |
| breast | 100% | 3052.68 | 459 / 459 | 100% | 46.12 | 1116 / 1118 |
| kidney | 100% | 3149.26 | 89 / 89 | 100% | 35.69 | 898 / 901 |
| bladder | 100% | 2691.14 | 21 / 21 | 100% | 43.86 | 502 / 504 |
| brain | 100% | 2940.67 | 2629 / 2642 | 100% | 44.94 | 705 / 705 |
| intestine | 100% | 2767.85 | 966 / 966 | 99% | 34.36 | 524 / 527 |
| adipose | 100% | 2927.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 42.42 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.44 | 29 / 29 |
| muscle | 100% | 3892.29 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3750.05 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 60.28 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.00 | 1 / 1 |
| blood vessel | 100% | 2105.44 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 3085.32 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1810.16 | 897 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051607 | Biological process | defense response to virus |
| GO_0016020 | Cellular component | membrane |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | ABCF3 |
| Protein name | ATP binding cassette subfamily F member 3 ATP-binding cassette sub-family F member 3 ATP-binding cassette sub-family F member 3 isoform 2 ATP-binding cassette sub-family F member 3 isoform 1 (ATP-binding cassette, sub-family F (GCN20), member 3, isoform CRA_a) |
| Synonyms | hCG_1790557 |
| Description | FUNCTION: Displays an antiviral effect against flaviviruses such as west Nile virus (WNV) in the presence of OAS1B. . |
| Accessions | A0A0S2Z645 ENST00000421340.5 Q9NUQ8 ENST00000292808.5 [Q9NUQ8-2] ENST00000429586.7 [Q9NUQ8-1] F8WCU6 A0A0S2Z5L1 |
